GLRA
DXCM icon

Gerald L. Ray & Associates’s DexCom DXCM Stock Holding History

Gerald L. Ray & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$552K Buy
45,100
+500
+1% +$8.84K 0.07% 218
2017
Q2 		$816K Buy
+44,600
New +$824K 0.11% 171

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gerald L. Ray & Associates's DXCM Position: Q3 2017 in Review

Gerald L. Ray & Associates increased its DexCom (DXCM) stake by 1.1% in Q3 2017, buying an estimated $8.84K and bringing the position to 45,100 shares worth $552K. The position accounts for 0.07% of the portfolio, ranked #218.

Gerald L. Ray & Associates first reported a position in DXCM in Q2 2017 and has held it in 2 quarters since. The position peaked at $816K in Q2 2017. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

  • Gerald L. Ray & Associates held 45,100 shares of DexCom worth $552K as of Q3 2017.
  • Gerald L. Ray & Associates bought 500 DexCom shares in Q3 2017, an estimated $8.84K.
  • DexCom made up 0.07% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #218 holding.
  • Gerald L. Ray & Associates first reported a position in DexCom in Q2 2017 and has held it in 2 quarters since.
  • Gerald L. Ray & Associates's DexCom position peaked at $816K in Q2 2017.
  • 275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.